A Study Evaluating Aprocitentan Tablets(SYH9108) for the Treatment of Resistant Hypertension
Clinical trial NCT07635914 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07635914
- Sponsor
- CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-31
- Primary completion
- 2029-12-28
- Enrollment
- 382
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.